# Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

> **NCT02011958** · PHASE3 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 59 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Liposomal Amphotericin B
- **DRUG:** Miltefosine

## Key facts

- **NCT ID:** NCT02011958
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-08
- **Final completion:** 2017-09-15
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02011958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02011958, "Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02011958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*